Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC)

Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC)

Background: Breast cancer represents one of the leading causes of death among women. Surgery can be effective, but once breast cancer has metastasized, it becomes extremely difficult to treat. Conventional therapies are associated with substantial toxicity and poor efficacy due to tumor heterogeneit...

Full description

Bibliographic Details
Main Authors: Caterina Lapenta, Stefano Maria Santini, Celeste Antonacci, Simona Donati, Serena Cecchetti, Patrizia Frittelli, Piera Catalano, Francesca Urbani, Iole Macchia, Massimo Spada, Sara Vitale, Zuleika Michelini, Domenico Cristiano Corsi, Ann Zeuner, Rosanna Dattilo, Manuela Tamburo De Bella
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Vaccines
Subjects:
cancer vaccines
immunotherapy
breast cancer
dendritic cells
Online Access:https://www.mdpi.com/2076-393X/12/9/1058

Internet

https://www.mdpi.com/2076-393X/12/9/1058

Similar Items